Arsenic Trioxide Induces Apoptosis in Human Colorectal Adenocarcinoma HT-29 Cells Through ROS
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: Treatment with arsenic trioxide (As2O3) results in a wide range of cellular effects that includes induction of apoptosis, inhibition of cell growth, promotion or inhibition of cellular differentiation, and inhibition of angiogenesis through a variety of mechanisms. The mechanisms of As2O3-induced cell death have been mainly studied in hematological cancers, and those mechanisms in solid cancers have yet to be clearly defined. In this study, the mechanisms by which As2O3 induces apoptosis in human colorectal adenocarcinoma HT-29 cells were investigated. Materials and Methods: To examine the levels of apoptosis, HT-29 cells were treated with As2O3 and then we measured the percentage of Annexin V binding cells, the amount of ROS production and the mitochondrial membrane potential. Western blot analysis was performed to identify the activated caspases after As2O3 exposure, and we compared the possible target molecules of apoptosis. As2O3 treatment induced the loss of the mitochondrial membrane potential and an increase of ROS, as well as activation of caspase-3, -7, -9 and -10. Results: As2O3 induced apoptosis via the production of reactive oxygen species and the loss of the mitochondrial membrane potential. As2O3 induced the activation of caspase-3, -7, -9 and -10. Furthermore, As2O3 treatment downregulates the Mcl-1 and Bcl-2 expressions, and the release of cytochrome c and an apoptosis-inducing factor (AIF). Pretreating the HT-29 cells with N-acetyl-L-cysteine, which is a thiol-containing antioxidant, inhibited the As2O3- induced apoptosis and caspase activation. Conclusion: Taken together, these results suggest that the generation of reactive oxygen species (ROS) by As2O3 might play an important role in the regulation of As2O3- induced apoptosis. This cytotoxicity is mediated through a mitochondria-dependent apoptotic signal pathway in HT-29 cells. (Cancer Res Treat. 2006;38:54-60)
Abstract
Purpose: Treatment with arsenic trioxide (As2O3) results in a wide range of cellular effects that includes induction of apoptosis, inhibition of cell growth, promotion or inhibition of cellular differentiation, and inhibition of angiogenesis through a variety of mechanisms. The mechanisms of As2O3-induced cell death have been mainly studied in hematological cancers, and those mechanisms in solid cancers have yet to be clearly defined. In this study, the mechanisms by which As2O3 induces apoptosis in human colorectal adenocarcinoma HT-29 cells were investigated. Materials and Methods: To examine the levels of apoptosis, HT-29 cells were treated with As2O3 and then we measured the percentage of Annexin V binding cells, the amount of ROS production and the mitochondrial membrane potential. Western blot analysis was performed to identify the activated caspases after As2O3 exposure, and we compared the possible target molecules of apoptosis. As2O3 treatment induced the loss of the mitochondrial membrane potential and an increase of ROS, as well as activation of caspase-3, -7, -9 and -10. Results: As2O3 induced apoptosis via the production of reactive oxygen species and the loss of the mitochondrial membrane potential. As2O3 induced the activation of caspase-3, -7, -9 and -10. Furthermore, As2O3 treatment downregulates the Mcl-1 and Bcl-2 expressions, and the release of cytochrome c and an apoptosis-inducing factor (AIF). Pretreating the HT-29 cells with N-acetyl-L-cysteine, which is a thiol-containing antioxidant, inhibited the As2O3- induced apoptosis and caspase activation. Conclusion: Taken together, these results suggest that the generation of reactive oxygen species (ROS) by As2O3 might play an important role in the regulation of As2O3- induced apoptosis. This cytotoxicity is mediated through a mitochondria-dependent apoptotic signal pathway in HT-29 cells. (Cancer Res Treat. 2006;38:54-60)
참고문헌 (24)
- "Arsenic trioxide, a therapeutic agent for APL", 20, pp.7146~7153 (2001)
- "Introduction: the history of arsenic trioxide in cancer therapy", 6, pp.1~2 (2001)
- "United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia", 19, pp.3852~3860
- "Caspase-independent cell death by arsenic trioxide in human cervical cancer cells", 64, pp.8960~8967 (2004)
- "Cellular mechanisms for the repression of apoptosis", 42, pp.259~281 (2002)
- "Apoptosis and therapy", 187, pp.127~137 (1999)
- "New approaches and therapeutics targeting apoptosis in disease", 57, pp.187~215 (2005)
- "Oxidative stress during myocardial ischaemia and heart failure", 10, pp.1699~1711 (2004)
- "Oxidative stress and redox-active iron in Alzheimer's disease", 1012, pp.179~182 (2004)
- "Hypoxia and oxidative stress in breast cancer", 3, pp.323~327 (2001)
- "ROS stress in cancer cells and therapeutic implications", 7(h), pp.97~110 (2004)
- "JC-1, but not DiOC6 (3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells", 411, pp.77~82 (1997)
- "Possible roles of nitric oxide and redox cell signaling in metal-induced toxicity and carcinogenesis", 19, pp.179~199 (2000)
- "Bcl-2 inhibits the mitochondrial release of an apoptogenic protease", 184, pp.1331~1341 (1996)
- "Apoptotic signaling pathways", 35, pp.24~27 (2002)
- "Programmed cell death: alive and well in the new millennium", 11, pp.526~534 (2001)
- "Cytochrome c and dATP-dependent formation of Apaf-1", caspase-9 complex initiates an apoptotic protease cascade, 1997, pp.91, 479~489
- "Mitochondria and apoptosis: new therapeutic targets", 85, pp.203~242 (2002)
- "Role of mitochondrial membrane permeabilization in apoptosis and cancer", 23(u jc), pp.2850~2860 (2004)
- "Mitochondrion as a novel target of anticancer chemotherapy", 92, pp.1042~1053 (2000)
- "The Bcl-2 protein family: arbiters of cell survival", 281, pp.1322~1626 (1998)
- "Reactive oxygen intermediates as mediators of programmed cell death in plants and animals", 57, pp.231~245 (1999)
- "Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway", 94, pp.2102~2111 (1999)
- "Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells", 101, pp.4578~4583 (2004)